LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes

Abstract

In this large study of type 2 diabetic patients, nearly 25% had elevated lipase or amylase levels without symptoms of acute pancreatitis. The clinician must take these data into account when evaluating abdominal symptoms in type 2 diabetic patients.

References

Page 1

	Year	Citations
Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus Peter A. Banks, Thomas L. Bollen, Christos Dervenis, Gut	2012	6.7K
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies Michael Elashoff, Aleksey V. Matveyenko, Belinda Gier, Gastroenterology Pancreatic CancerMedicinePathologyPeptide TherapeuticsOncology	2011	911
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus Sonal Singh, Hsien‐Yen Chang, Thomas M. Richards, JAMA Internal Medicine	2013	445
Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors Alexandra E. Butler, Martha Campbell‐Thompson, Tatyana Gurlo, Diabetes PathologyInsulin SignalingTumor BiologyIncretin TherapyPancreatic Cancer	2013	441
Increased Risk of Acute Pancreatitis and Biliary Disease Observed in Patients With Type 2 Diabetes Rebecca Noel, Daniel Braun, Ruth E. Patterson, Diabetes Care	2009	431
Adipocyte Lipases and Defect of Lipolysis in Human Obesity Dominique Langin, Andrea Dicker, Geneviève Tavernier, Diabetes	2005	361
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide David D. Dore, John D. Seeger, K. Arnold Chan Current Medical Research and Opinion	2009	329
Acute Pancreatitis in Type 2 Diabetes Treated With Exenatide or Sitagliptin Rajesh Garg, William Chen, Merri Pendergrass Diabetes Care	2010	321
Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial Steven P. Marso, Neil R Poulter, Steven E. Nissen, American Heart Journal	2013	241
Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes Cynthia J. Girman, Tzuyung D. Kou, Benjamin Cai, Diabetes Obesity and Metabolism	2010	217

Page 1